Paul Dougall
About Paul Dougall
Paul Dougall is a Product Manager specializing in Rare Disease at SOPHiA GENETICS, where he has worked since 2021. He has extensive experience in product management and a strong academic background in drug delivery and chemistry.
Work at SOPHiA GENETICS
Paul Dougall has been serving as the Product Manager for Rare Disease at SOPHiA GENETICS since 2021. In this role, he focuses on developing and managing products that leverage advanced genomic technologies to address rare diseases. His responsibilities include overseeing product strategy, collaborating with cross-functional teams, and ensuring that the products meet the needs of healthcare professionals and patients. Dougall's expertise in Next Generation Sequencing enhances the company's ability to provide innovative solutions in the field of rare disease diagnostics.
Previous Experience in Product Management
Prior to his current role, Paul Dougall worked as the Global Product Manager for Cytogenetics and Rare Disease at Oxford Gene Technology from 2020 to 2021. His experience also includes a position as Product Manager at Bio-Techne from 2017 to 2020, where he managed product lines and contributed to market strategies. His earlier role as a Research Scientist in Biochemistry at Mars Petcare provided him with a strong foundation in scientific research and product development.
Education and Expertise
Paul Dougall holds a Doctor of Philosophy (Ph.D.) in Drug Delivery from the University of Nottingham, which he completed from 2011 to 2015. He also earned a Master of Science (M.Sc.) in Drug Discovery and Development from the University of Aberdeen in 2011. His academic journey began with a Bachelor's Degree in Chemistry with Medicinal Chemistry from The University of Glasgow, completed in 2010. Dougall's educational background equips him with a deep understanding of pharmaceutical sciences and product development.
Skills and Special Interests
Paul Dougall possesses a range of skills relevant to product management, including market and competitor analysis, pricing strategies, and marketing. He is adept at managing intellectual property and license negotiations. His special interest in Next Generation Sequencing allows him to investigate cytogenetics and rare diseases effectively. Dougall is also experienced in AI-powered data interpretation, which plays a crucial role in strategic product management and enhances decision-making processes.